AT351184B - Verfahren zum herstellen von neuen optisch aktiven formen oder racemischen gemischen von prostaglandinen - Google Patents

Verfahren zum herstellen von neuen optisch aktiven formen oder racemischen gemischen von prostaglandinen

Info

Publication number
AT351184B
AT351184B AT656075A AT656075A AT351184B AT 351184 B AT351184 B AT 351184B AT 656075 A AT656075 A AT 656075A AT 656075 A AT656075 A AT 656075A AT 351184 B AT351184 B AT 351184B
Authority
AT
Austria
Prior art keywords
prostaglandines
optically active
racemic mixtures
producing new
new optically
Prior art date
Application number
AT656075A
Other languages
English (en)
Other versions
ATA656075A (de
Original Assignee
Erba Farmitalia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Farmitalia filed Critical Erba Farmitalia
Publication of ATA656075A publication Critical patent/ATA656075A/de
Application granted granted Critical
Publication of AT351184B publication Critical patent/AT351184B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4018Esters of cycloaliphatic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds
    • C07F9/5407Acyclic saturated phosphonium compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/564Three-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/58Pyridine rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
AT656075A 1974-09-25 1975-08-25 Verfahren zum herstellen von neuen optisch aktiven formen oder racemischen gemischen von prostaglandinen AT351184B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT27654/74A IT1053781B (it) 1974-09-25 1974-09-25 Omega nor cicloalcil 13.14 deidro prostaglandine

Publications (2)

Publication Number Publication Date
ATA656075A ATA656075A (de) 1978-12-15
AT351184B true AT351184B (de) 1979-07-10

Family

ID=11222055

Family Applications (1)

Application Number Title Priority Date Filing Date
AT656075A AT351184B (de) 1974-09-25 1975-08-25 Verfahren zum herstellen von neuen optisch aktiven formen oder racemischen gemischen von prostaglandinen

Country Status (24)

Country Link
US (2) US4035415A (de)
JP (2) JPS5839156B2 (de)
AT (1) AT351184B (de)
BE (1) BE832983A (de)
CA (1) CA1083569A (de)
CH (1) CH617186A5 (de)
CS (1) CS191276B2 (de)
CY (1) CY954A (de)
DE (1) DE2539116C2 (de)
DK (1) DK155316C (de)
FI (1) FI63932C (de)
FR (2) FR2285866A1 (de)
GB (1) GB1483880A (de)
HK (1) HK42478A (de)
HU (1) HU174287B (de)
IL (1) IL48043A (de)
IT (1) IT1053781B (de)
KE (1) KE2851A (de)
MY (1) MY7800321A (de)
NL (1) NL187354C (de)
NO (1) NO146357C (de)
SE (1) SE422057B (de)
SU (1) SU652889A3 (de)
ZA (1) ZA755420B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU501803B2 (en) * 1975-03-21 1979-06-28 Farmitalia Carlo Erba S.P.A. Fluoro-prostaglandins
DE2655004C3 (de) * 1976-12-02 1980-06-19 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur Herstellung von bicyclischen Laktonen
IT1088966B (it) * 1977-11-15 1985-06-10 Erba Carlo Spa 13,14-dideidro-prostaglandine
US4543353A (en) * 1981-11-27 1985-09-24 Farmitalia Carlo Erba S.P.A. Ester and amide derivatives of 13,14-didehydro prostaglandins
JP2721414B2 (ja) * 1988-09-06 1998-03-04 フアーマシア・アンド・アツプジヨン・アー・ベー 縁内障または眼圧亢進の治療のためのプロスタグランジン誘導体
DE4024347A1 (de) * 1990-07-27 1992-01-30 Schering Ag Cyclopentanderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung
US5741810A (en) * 1996-02-29 1998-04-21 Allergan Cyclopentane heptan(ene)oic acid, 2- heteroarylalkenyl derivatives as therapeutic agents
CZ2013987A3 (cs) * 2013-12-10 2015-06-17 Univerzita Pardubice Způsob přípravy (3aR,4S,5R,6aS)-4-[(3S)-5-cyklohexyl-3-hydroxypent-1-yn-1-yl]-5-(ethoxymethoxy)-hexahydro-2H-cyklopenta[b]furan-2-onu

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3843713A (en) * 1972-04-05 1974-10-22 Ciba Geigy Corp 16-lower alkoxy lower alkyl,-16-20 w-pentano,pge
GB1425962A (en) * 1972-04-13 1976-02-25 Erba Carlo Spa Lactols and lactones
US3876690A (en) * 1973-05-11 1975-04-08 American Cyanamid Co 1-alkoxy-9-keto-prostenoic acid derivatives
US3884909A (en) * 1973-09-24 1975-05-20 Standard Brands Inc Gelatinizable crosslinked cationic starch and method for its manufacture
IT1044796B (it) * 1974-09-06 1980-04-21 Erba Carlo Spa Pgf beta gandolfi
FI71138C (fi) * 1976-12-31 1986-11-24 Erba Farmitalia Foerfarande foer framstaellning av terapeutiskt aktiva bisykliska prostaglandiner

Also Published As

Publication number Publication date
DE2539116A1 (de) 1976-04-08
HK42478A (en) 1978-08-11
JPS58135858A (ja) 1983-08-12
FR2285866A1 (fr) 1976-04-23
MY7800321A (en) 1978-12-31
KE2851A (en) 1978-07-21
JPS5839156B2 (ja) 1983-08-27
DE2539116C2 (de) 1984-08-02
NL7510452A (nl) 1976-03-29
IT1053781B (it) 1981-10-10
CS191276B2 (en) 1979-06-29
SE7509764L (sv) 1976-03-26
IL48043A (en) 1979-12-30
US4361577A (en) 1982-11-30
DK155316C (da) 1989-08-14
SE422057B (sv) 1982-02-15
NO146357B (no) 1982-06-07
FI752491A (de) 1976-03-26
IL48043A0 (en) 1975-11-25
SU652889A3 (ru) 1979-03-15
CA1083569A (en) 1980-08-12
AU8381075A (en) 1977-02-10
BE832983A (fr) 1976-03-02
JPS5918391B2 (ja) 1984-04-26
US4035415A (en) 1977-07-12
FI63932C (fi) 1983-09-12
DK155316B (da) 1989-03-28
FR2378757A1 (fr) 1978-08-25
NL187354C (nl) 1991-09-02
JPS51125044A (en) 1976-11-01
CH617186A5 (de) 1980-05-14
NO146357C (no) 1982-09-15
GB1483880A (en) 1977-08-24
NO753028L (de) 1976-03-26
FR2285866B1 (de) 1978-12-22
HU174287B (hu) 1979-12-28
FR2378757B1 (de) 1980-07-04
FI63932B (fi) 1983-05-31
CY954A (en) 1978-12-22
DK390975A (da) 1976-03-26
ATA656075A (de) 1978-12-15
ZA755420B (en) 1977-04-27

Similar Documents

Publication Publication Date Title
AT339040B (de) Verfahren zum herstellen von katalytischen zusammensetzungen
AT351684B (de) Verfahren zur herstellung von neuen optisch aktiven oder racemischen verbindungen
AT351274B (de) Verfahren zum herstellen von vorformlingen
AT338526B (de) Verfahren zum kontinuierlichen herstellen von polyamiden
AT351184B (de) Verfahren zum herstellen von neuen optisch aktiven formen oder racemischen gemischen von prostaglandinen
AT315716B (de) Verfahren zum Herstellen von Kunstbeton-Bauteilen
AT351181B (de) Verfahren zur herstellung von neuen thia- prostaglandinen
AT336374B (de) Verfahren zum herstellen von drahtgittern
AT341459B (de) Verfahren zur aufbereitung von montmorillonit
AT351183B (de) Verfahren zur herstellung von neuen prosta- glandinen
AT322948B (de) Verfahren zum herstellen von schienen
AT356099B (de) Verfahren zur herstellung von neuen dibenzo- furanderivaten und salzen hievon
AT352712B (de) Verfahren zur herstellung von neuen 1-alkyl-2- (phenoxymethyl)-5-nitroimidazolen
AT357699B (de) Verfahren zum herstellen von neuen 13,14- dehydro-11-deoxy-prostaglandinen
AT341516B (de) Verfahren zur herstellung von neuen indol-2-carbaldehyden
AT329784B (de) Verfahren zum herstellen von gussblocken
ATA329975A (de) Verfahren zum aufkonzentrieren von latices
ATA3875A (de) Verfahren zum behandeln von abwasser
ATA557474A (de) Verfahren zum herstellen von stahlblocken
ATA305378A (de) Verfahren zum herstellen von neuen pgfbeta- -prostaglandinen
ATA876775A (de) Verfahren zur herstellung von stahlbloecken
AT338418B (de) Verfahren zur herstellung von neuen penamderivaten
AT338758B (de) Verfahren zur herstellung von neuen o-halogen-isopropenylbenzolen
ATA762578A (de) Verfahren zum herstellen von neuen optisch aktiven prost-5-en-13-in-carbonsaeurederivaten
CH539486A (de) Verfahren zum Herstellen von Werkzeugen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1317478

Country of ref document: EP